Evan Walker, MD
Assistant Professor
Medicine
School of Medicine

Dr. Walker is a medical oncologist with a specific focus on gastrointestinal cancers. He maintains clinical practices at UCSF and the San Francisco VA.

Education & Training

Show all (6) Hide

• Diversity, Equity, and Inclusion Champion Training UCSF 2021
• Medical Oncology Fellowship UCSF 2019-21
• Chief Residency UCSF 2018-19
• Residency Medicine UCSF 2015-18
• MD UCSF 2010-15
• ScB Biology Brown University 2006-10

Publications (27)

Top publication keywords:
HypercholesterolemiaGenetic CounselingCarcinoma, Pancreatic DuctalAdvance Care PlanningGenetic TestingBenzamidesGastrointestinal Stromal TumorsDocumentationGastrointestinal NeoplasmsHepatitis B virusReferral and ConsultationHypolipidemic AgentsPancreatic NeoplasmsMetforminAdenocarcinoma

• Challenges in patient-centered germline testing delivery for veterans with advanced prostate cancer (APC).
  Journal of Clinical Oncology 2024 Daniel H Kwon, Marissa McPhaul, Eliza Hearst, Saffanat Sumra, Carling Jade Ursem, Evan Justin Walker, Maren Theresa Scheuner, Sunny Wang, Rahul Raj Aggarwal, Franklin W. Huang, Jeffrey Belkora
• Results of the safety and tolerability of ivaltinostat plus capecitabine in the phase 1b portion of a phase 1b/2, dose-escalation, randomized, multi-center study in the maintenance (maint) setting in patients with metastatic pancreatic adenocarcinoma (mPDAC).
  Journal of Clinical Oncology 2024 Evan Justin Walker, Christos Fountzilas, Erkut Hasan Borazanci, Anthony F. Shields, James Thomas D'Olimpio, J. Randolph Hecht, Shou-Ching Tang, Glenn Michelson, Lorna Liganor, Sangsook Ahn Cho, Andrew…
• Maintenance Treatment for Metastatic Pancreatic Cancer: Balancing Therapeutic Intensity with Tolerable Toxicity.
  Cancers 2023 Walker EJ, Ko AH
• A phase 1b/2, dose-escalation, randomized, multicenter study of maintenance (maint) ivaltinostat (ival) plus capecitabine (cap) or capecitabine monotherapy in patients (pts) with metastatic pancreatic adenocarcinoma (PDAC) whose disease has not progressed on first-line FOLFIRINOX chemotherapy (CT).
  Journal of Clinical Oncology 2022 Evan Justin Walker, Erkut Hasan Borazanci, Gehan Botrus, Christos Fountzilas, J. Randolph Hecht, Anup Kasi, Niharika B. Mettu, Shubham Pant, Glenn Michelson, Gene Cho, Sangsook Ahn Cho, Lorna Liganor,…
• The Gut Microbiome in Colorectal Cancer.
  Hematology/oncology clinics of North America 2022 Piawah S, Walker EJ, Van Blarigan EL, Atreya CE

Show all (22 more) Hide

• The Additional Diagnostic Benefit of Pancreatic Cancer Molecular Profiling After Germline Testing.
  Pancreas 2022 Walker EJ, Blanco AM, Carnevale J, Cinar P, Collisson EA, Tempero MA, Ko AH
• The VA My Life My Story Project: Keeping Medical Students and Veterans Socially Connected While Physically Distanced.
  Federal practitioner : for the health care professionals of the VA, DoD, and PHS 2021 Walker E, Bruns E, Dhaliwal G
• Implementation of an Embedded In-Clinic Genetic Testing Station to Optimize Germline Testing for Patients with Pancreatic Adenocarcinoma.
  The oncologist 2021 Walker EJ, Goldberg D, Gordon KM, Pedley C, Carnevale J, Cinar P, Collisson EA, Tempero MA, Ko AH, Blanco AM, Dhawan M
• Durable response after immune checkpoint inhibitor-related diabetes in mismatch repair-deficient pancreatic cancer.
  Immunotherapy 2021 Tsang ES, Walker EJ, Carnevale J, Fisher GA, Ko AH
• Investigating tumor molecular profiling as a possible contributor to racial/ethnic disparities in pancreatic cancer.
  Journal of Clinical Oncology 2021 Evan Justin Walker, Sorbarikor Piawah, Ann Griffin, Julia C. Carnevale, Pelin Cinar, Eric Andrew Collisson, Margaret A. Tempero, Andrew H. Ko
• Anxious, Depressed, and Planning for the Future: Advance Care Planning in Diverse Older Adults.
  Journal of the American Geriatrics Society 2020 McMahan RD, Barnes DE, Ritchie CS, Jin C, Shi Y, David D, Walker EJ, Tang VL, Sudore RL
• Postoperative Exacerbation of Oxaliplatin-induced Neurotoxicity in Gastrointestinal Cancers: A Case Series.
  Anticancer research 2020 Gonzalez A, Walker EJ, Van Loon K, Cinar P, Atreya CE
• Referral frequency, attrition rate, and outcomes of germline testing in patients with pancreatic adenocarcinoma.
  Familial cancer 2019 Walker EJ, Carnevale J, Pedley C, Blanco A, Chan S, Collisson EA, Tempero MA, Ko AH
• A Protean Protein.
  Journal of hospital medicine 2018 Nawas MT, Walker EJ, Richie MB, White AA, Hsu G
• Interprofessional primary care electronic intervention to reduce hypoglycaemic agent use in high-risk veterans with diabetes.
  BMJ open quality 2018 Upadhyay V, Walker E, Govea A, Rife T, Jimenez I, Dulay M, Beaman J
• Advance Care Planning Documentation Practices and Accessibility in the Electronic Health Record: Implications for Patient Safety.
  Journal of pain and symptom management 2017 Walker E, McMahan R, Barnes D, Katen M, Lamas D, Sudore R
• A Phase I Study of FOLFIRINOX Plus IPI-926, a Hedgehog Pathway Inhibitor, for Advanced Pancreatic Adenocarcinoma.
  Pancreas 2016 Ko AH, LoConte N, Tempero MA, Walker EJ, Kate Kelley R, Lewis S, Chang WC, Kantoff E, Vannier MW, Catenacci DV, Venook AP, Kindler HL
• Statin use and risk of pancreatic cancer: results from a large, clinic-based case-control study.
  Cancer 2015 Walker EJ, Ko AH, Holly EA, Bracci PM
• A patient with cholangiocarcinoma demonstrating pathologic complete response to chemotherapy: exploring the role of neoadjuvant therapy in biliary tract cancer.
  Journal of gastrointestinal oncology 2014 Walker EJ, Simko JP, Nakakura EK, Ko AH
• Metformin use among type 2 diabetics and risk of pancreatic cancer in a clinic-based case-control study.
  International journal of cancer 2014 Walker EJ, Ko AH, Holly EA, Bracci PM
• Hepatitis B viral reactivation secondary to imatinib treatment in a patient with gastrointestinal stromal tumor.
  Anticancer research 2014 Walker EJ, Simko JP, Ko AH
• Beyond first-line chemotherapy for advanced pancreatic cancer: an expanding array of therapeutic options?
  World journal of gastroenterology 2014 Walker EJ, Ko AH
• Loss of the SxxSS motif in a human T-cell factor-4 isoform confers hypoxia resistance to liver cancer: an oncogenic switch in Wnt signaling.
  PloS one 2012 Koga H, Tsedensodnom O, Tomimaru Y, Walker EJ, Lee HC, Kim KM, Yano H, Wands JR, Kim M
• Abstract 1933: Preferential ubiquitination of hypoxia-inducible factors depends on the SxxSS motif in human T-cell factor-4 isoforms derived from hepatocellular carcinoma.
  Cancer Research 2011 Hironori Koga, Evan J. Walker, Orkhontuya Tsedensodnom, Jack R. Wands, Miran Kim
• Role of Raf Kinase Inhibitor Protein in Hepatocellular Carcinoma.
  Forum on immunopathological diseases and therapeutics 2011 Walker EJ, Rosenberg SA, Wands JR, Kim M
• Abstract 4067: A T-cell factor-4 motif regulates the phenotype of hepatocellular carcinoma cells.
  Cancer Research 2010 Hironori Koga, Evan J. Walker, Orkhontuya Tsedensodnom, Jack R. Wands, Miran Kim
• Low density contrast agents for x-ray phase contrast imaging: the use of ambient air for x-ray angiography of excised murine liver tissue.
  Physics in medicine and biology 2008 Laperle CM, Hamilton TJ, Wintermeyer P, Walker EJ, Shi D, Anastasio MA, Derdak Z, Wands JR, Diebold G, Rose-Petruck C